Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Most Viewed

  • Published in last 1 year
  • In last 2 years
  • In last 3 years
  • All
Please wait a minute...
  • 1.
    Expert consensus on the operating specifications of robot-assisted percutaneous surgery system in percutaneous lung puncture for diagnosis and treatment
    Fei Cui, Yanwei Chen, Xingyang Xue, Jun Liu, Wenlong Shao, Fa Long, Yu Li, Chundong Gu, Jian Zhang, Honghao Zhang, Xin Li, Shiyue Li, Jianxing He
    Chinese Journal of Thoracic Surgery(Electronic Edition) 2025, 12 (01): 1-11. DOI: 10.3877/cma.j.issn.2095-8773.2025.01.01
    Abstract (1018) HTML (77) PDF (16288 KB) (428)

    Lung cancer is a malignant tumor with the highest morbidity and mortality both in China and even in the world.Accurate diagnosis and treatment of this disease are crucial to improving the survival and quality of life of patients.Computed tomography (CT)-guided percutaneous lung puncture is an important method for the diagnosis and treatment of lung diseases,but heavily relies on doctors' professional skills and surgical experience in practices.The robot-assisted percutaneous surgery system integrates a series of emerging technologies to improve the accuracy and safety of percutaneous lung puncture,reduce the difficulty of operation,and reduce the occurrence of complications through puncture path planning,respiratory movement monitoring,robot-assisted positioning,etc.This technology has been increasingly used in clinical scenarios,such as lung biopsy,ablation,and preoperative localization for thoracoscopic surgery.In order to standardize the operating procedures of CT-guided percutaneous lung puncture for diagnosis,treatment and localization with the robot-assisted percutaneous surgery system and to summarize key points,Guangdong Association of Thoracic Diseases organized experts from various fields (thoracic surgery,respiratory medicine,oncology,interventional therapy,etc.) to develop this expert consensus.

  • 2.
    Current status of research on the application of artificial intelligence in lung nodule prediction modeling
    Yujie Ma, Yuhe You, Zhe Piao, Hongsheng Xue, Wenjun Cao, Zhen Wang, Zhilong Zhao
    Chinese Journal of Thoracic Surgery(Electronic Edition) 2025, 12 (01): 39-48. DOI: 10.3877/cma.j.issn.2095-8773.2025.01.05
    Abstract (616) HTML (50) PDF (1347 KB) (58)

    Lung nodules are a common chest imaging manifestation,which has received extensive attention from the clinic and society.In recent years, artificial intelligence (AI) technology based on computed tomography (CT) images has matured and has been widely applied in the classification of lung nodule detection,pathologic typing,malignancy degree and gene mutation prediction.The aim of this paper is to sort out and analyze the relevant studies of AI in the field of lung nodule diagnosis and treatment.

  • 3.
    Advances in total neoadjuvant therapy strategies for esophageal and esophagogastric junction cancers
    Xiaozheng Kang, Ruixiang Zhang, Zhen Wang, Xiankai Chen, Xiaobin Shang, Yong Li, Jianjun Qin, Yin Li
    Chinese Journal of Thoracic Surgery(Electronic Edition) 2025, 12 (03): 176-184. DOI: 10.3877/cma.j.issn.2095-8773.2025.03.07
    Abstract (423) HTML (14) PDF (3928 KB) (28)

    Esophageal cancer and esophagogastric junction cancer are highly prevalent malignant tumors in China, and most patients are diagnosed at an advanced stage. Neoadjuvant therapy has become the standard treatment for locally advanced patients. However, although traditional neoadjuvant chemoradiotherapy (nCRT) can improve the surgical resection rate, the distant metastasis rate remains high, indicating that the treatment strategy needs further optimization. Total neoadjuvant therapy (TNT) overcomes the drug resistance caused by tumor heterogeneity from the spatiotemporal dimension through early intensive systemic therapy, multidrug sequential combination, and dynamic adaptive adjustment, showing good prospects in both esophageal adenocarcinoma and squamous cell carcinoma. Existing studies have shown that the TNT strategy can improve the R0 resection rate in esophageal adenocarcinoma [for example, the pathological complete response rate (pCR) of the FLOT regimen (docetaxel + oxaliplatin + leucovorin + 5-fluorouracil) reaches 20%], and nCRT combined with immunotherapy (such as atezolizumab) can further improve survival [the 2-year overall survival (OS) rate in the PERFECT trial reaches 92%]. In esophageal squamous cell carcinoma, immunotherapy combined with nCRT significantly increases the pCR rate (55.6% in the PALACE-1 study and 63.2% in the CRIS study), and specific biomarkers (such as TCF-1+ T cells) may predict therapeutic efficacy. However, the toxicity management of TNT (such as lymphopenia) and the optimal treatment sequence still need further optimization. Future research directions include: developing a dynamic monitoring system for ctDNA to guide individualized treatment; exploring innovative combinations such as dual immunotherapy blockade and antibody-drug conjugates; and verifying long-term survival benefits through phase Ⅲ clinical trials (such as KEYNOTE-975 and EA2174). Multidisciplinary collaboration and precision immunotherapy will drive the innovation of neoadjuvant therapy for esophageal cancer.

  • 4.
    Experience in diagnosis and treatment of bronchopleural fistula after lung resection
    Yuhe You, Hongsheng Xue, Wenjun Cao, Liang Wang, Yujie Ma, Zhe Piao, Yanying Wu, Zhilong Zhao
    Chinese Journal of Thoracic Surgery(Electronic Edition) 2025, 12 (01): 33-38. DOI: 10.3877/cma.j.issn.2095-8773.2025.01.04
    Abstract (299) HTML (29) PDF (4512 KB) (54)

    Objective

    To summarize the clinical data of bronchopleural fistula (BPF) patients,analyze the causes, and explore the treatment methods and efficacy.

    Methods

    From April 2021 to June 2024 in Department of Thoracic Surgery,Affiliated Zhongshan Hospital of Dalian Uninersity,6 patients with BPF after lung resection were treated with bronchoscopy (injection of polidocanol around the bronchial fistula) and surgical intervention after the failure of conservative treatment.

    Results

    Among the 6 patients,4 were males and 2 were females,aged 60 years on average;5 patients underwent right lower lobe resection;3 patients had a long history of smoking;1 patient had diabetes mellitus;3 patients had combined anemia and hypoproteinemia.The mean length of the bronchial stump was (0.8±0.4) cm.The median time to postoperative BPF was 71.5 days.One patient underwent thoracoscopic BPF repair.Five patients were treated with endoscopic injection of sclerosing agent,and one of them had R1 resection,failed endoscopic treatment,and was transferred to surgical repair,with a success rate of interventional therapy of 80%.After follow-up of 3 to 40 months,BPF was healed.

    Conclusion

    Combining a large amount of relevant research,our group found that BPF after lung resection is related to smoking,malnutrition,right lower lobe surgery,and R1 resection.Endoscopic sclerotherapy is effective,yet surgery remains the final treatment.

  • 5.
    Single-port thoracoscopic for lobectomy of right lower lobe anteriorbasal segment
    Zhexin Wang, Zhiming Bi, Feng Yao
    Chinese Journal of Thoracic Surgery(Electronic Edition) 2025, 12 (01): 49-50. DOI: 10.3877/cma.j.issn.2095-8773.2025.01.06
  • 6.
    Artificial intelligence-driven neoadjuvant precision treatment of esophageal cancer
    Yiming Xu, Xueyuan Fan, Shihao Li, Yifan Xu, Bowen Li, Zhenyang Geng, Yafei Liu, Guanchao Ye, Feng Li, Lan Huang, Yu Qi
    Chinese Journal of Thoracic Surgery(Electronic Edition) 2025, 12 (02): 96-104. DOI: 10.3877/cma.j.issn.2095-8773.2025.02.04
    Abstract (246) HTML (20) PDF (6143 KB) (58)

    Esophageal cancer is a highly aggressive digestive tract malignancy with a poor prognosis.Its treatment strategies require individualization and precision.Recent advances in artificial intelligence (AI) have enhanced various aspects of esophageal cancer treatment, significantly improving the accuracy of treatment outcome prediction,treatment plan formulation,and dynamic intervention.This article systematically reviews the core applications and recent progress of AI in the treatment of esophageal cancer,and discusses the challenges and future directions for its clinical application.

  • 7.
    Impact of adjuvant chemotherapy on survival for patients with completely resected stage T2bN0M0 non-small cell lung cancer
    Danwen Zhao, Dandan Liu, Wendeng Li, Ranran Kong, Shiyuan Liu
    Chinese Journal of Thoracic Surgery(Electronic Edition) 2025, 12 (01): 12-23. DOI: 10.3877/cma.j.issn.2095-8773.2025.01.02
    Abstract (217) HTML (12) PDF (1907 KB) (28)

    Objective

    To estimate the impact of adjuvant chemotherapy on survival in T2bN0M0 nonsmall cell lung cancer(NSCLC)patients.

    Methods

    The clinicopathological data of patients with stage T2bN0M0 NSCLC who underwent lobectomy and mediastinal lymph node dissection between 2010 and 2015 were retrospectively analyzed in the Surveillance,Epidemiology,and End Results(SEER)database.The risk factors were identified by Cox regression.Propensity score matching(PSM)analysis and Kaplan-Meier curves were used to compare the cancerspecific survival(CSS)and overall survival(OS)of T2bN0M0 NSCLC patients between the non-adjuvant chemotherapy and adjuvant chemotherapy groups.

    Results

    A total of 538 patients with completely resected stage T2bN0M0 NSCLC were enrolled in this study,including 285 males and 253 females,with a median age of 69(62-75)years.Patients with younger,grade III-IV were more likely to receive chemotherapy(P<0.05).In Cox regression,adjuvant chemotherapy was significantly associated with OS in completely resected stage T2N0M0 NSCLC(hazard ratio =0.52,95% confidence interval 0.36-0.74,P<0.05).In the total population,patients treated with adjuvant chemotherapy had a better OS than those not treated with adjuvant chemotherapy before and after PSM(P<0.05).In addition,adjuvant chemotherapy can bring a survival benefit for patients <70 years old,but does not improve OS for patients≥70 years old.Similarly,for poor-to-undifferentiated patients,adjuvant chemotherapy can improve the OS of patients,but for moderate-to-well differentiated patients,adjuvant chemotherapy cannot bring survival benefit.

    Conclusion

    Adjuvant chemotherapy contribute to a survival benefit in completely resected stage T2bN0M0 NSCLC patients,especially in patients <70 years and poor-to-undifferentiated NSCLC patients.Adjuvant chemotherapy should be considered in completely resected stage T2bN0M0 NSCLC patients.

  • 8.
    Thoracoscopic for lobectomy of left upper lobe proper segment
    Ruijun Liu, Tao Pan, Yu Zhang
    Chinese Journal of Thoracic Surgery(Electronic Edition) 2025, 12 (01): 51-51. DOI: 10.3877/cma.j.issn.2095-8773.2025.01.07
    Abstract (211) HTML (0) PDF (1137 KB) (1)
  • 9.
    Uniportal thoracoscopic right superior segmentectomy
    Jiantao Li, Xingshi Chen, Qingquan Luo
    Chinese Journal of Thoracic Surgery(Electronic Edition) 2025, 12 (02): 116-116. DOI: 10.3877/cma.j.issn.2095-8773.2025.02.07
  • 10.
    Lung cancer laterality and prognosis of second lung cancer: a retrospective study of the SEER database
    Liangbin Pan, Nan Wang, Haitao Ma, Kai Xie
    Chinese Journal of Thoracic Surgery(Electronic Edition) 2025, 12 (02): 66-82. DOI: 10.3877/cma.j.issn.2095-8773.2025.02.02
    Abstract (170) HTML (8) PDF (6641 KB) (17)

    Objective

    To clarify the influence of the tumor-lateral nature (left/right) of second lung cancer(SLC) and its interaction with the extent of previous lung resection on the 5-year overall survival rate of patients.

    Methods

    Using data in the Surveillance, Epidemiology, and End Results(SEER)database from 1975 to 2018,the study enrolled the SLC patients with a history of surgery for lung malignancy.Kaplan-Meier survival analysis and Cox proportional risk model were used to investigate the effect of malignancy on 5-year overall survival in SLC patients.

    Results

    A total of 4 693 patients with SLC were screened,including 2 587 patients with right-sided SLC and 2 106 patients with left-sided SLC.The results of multivariate analysis showed that the SLC on the right side was an independent risk factor for poor prognosis of subjects[hazard ratio(HR):1.115,95% confidence interval(CI):1.036~1.200,P=0.004],and the position of the two lung cancers on the opposite laterality was also associated with the lower 5-year overall survival rate(HR:1.086,95% CI:1.006~1.172,P=0.034).

    Conclusion

    Tumor laterality is a key factor affecting the prognosis of SLC and may have a synergistic effect with the anatomical changes after previous lung resection.The survival disadvantage of patients with right SLC suggests that in the selection of surgical methods and postoperative follow-up,the risk assessment and individualized intervention of the right lung should be strengthened in order to improve the long-term prognosis.

  • 11.
    Efficacy of thoracoscopic indocyanine green fluorescence imaging of the thoracic duct in preventing chylothorax after minimally invasive McKeown esophagectomy
    Hanran Wu, Changqing Liu, Xianning Wu, Gao Wu, Li Du, Li Zhang, Xinyu Mei
    Chinese Journal of Thoracic Surgery(Electronic Edition) 2025, 12 (02): 55-65. DOI: 10.3877/cma.j.issn.2095-8773.2025.02.01
    Abstract (163) HTML (17) PDF (7344 KB) (25)

    Objective

    To evaluate the efficacy of indocyanine green (ICG) fluorescence imaging of the thoracic duct in preventing chylothorax after minimally invasive McKeown esophagectomy(MIME).

    Methods

    A retrospective analysis was conducted on 174 patients who underwent MIME for esophageal cancer at the Department of Thoracic Surgery,The First Affiliated Hospital of the University of Science and Technology of China (January to December 2024).Patients were divided into two groups: the ICG imaging of the thoracic duct(ITD)group(n=61)and the non-ICG imaging of the thoracic duct(NITD)group(n=113).Clinical data,perioperative parameters and postoperative complications were compared.Univariate and multivariate analyses were performed to identify risk factors for chylothorax.

    Results

    A total of 174 patients were included,including 141 males and 33 females with a mean age of 68.56±12.02 years.No significant differences were observed between the ITD and NITD groups in age,sex,tumor location,pathological type,differentiation grade,preoperative comorbidities,neoadjuvant therapies(chemotherapy,chemoradiotherapy,or chemoradiotherapy with immunotherapy),operative time,intraoperative blood loss,hospital stay,or lymph node dissection(P>0.05).Significant differences were noted in preoperative neoadjuvant chemotherapy combined with immunotherapy,intraoperative thoracic duct ligation,thoracic duct injury,pT stage,pN stage,and pTNM stage(P<0.05).The incidence of chylothorax was significantly lower in the ITD group compared to the NITD group(P<0.05).No differences were observed in other minor complications(atelectasis,anastomotic leakage,pleural effusion,pneumonia,hoarseness,arrhythmia)or major complications(pleural effusion,hemorrhage,anastomotic leakage,arrhythmia)(P>0.05).Univariate and multivariate analysis confirmed that intraoperative thoracic duct imaging was an independent protective factor against chylothorax(P=0.048).

    Conclusion

    ICG fluorescence imaging of the thoracic duct effectively reduces the incidence of chylothorax after minimally invasive McKeown esophagectomy.

  • 12.
    The research progress and prospects of targeting cancer-associated fibroblasts in lung cancer therapy
    Qianhe Ren, Susu Yang, Yue Yu
    Chinese Journal of Thoracic Surgery(Electronic Edition) 2025, 12 (02): 105-111. DOI: 10.3877/cma.j.issn.2095-8773.2025.02.05
    Abstract (158) HTML (16) PDF (6177 KB) (35)

    Current therapeutic strategies for lung cancer remain suboptimal, underscoring the urgent need for novel treatment approaches and targets of clinical relevance.In recent years,a growing body of evidence has highlighted the pivotal role of tumor microenvironment (TME) abnormalities in the initiation and progression of lung cancer.Among the various stromal components,cancer-associated fibroblasts (CAFs) have emerged as key regulators of the malignant phenotype,significantly influencing tumor cell proliferation,invasion,and metastasis.As integral constituents of the TME,CAFs are essential for maintaining normal cellular physiology.However,when aberrantly activated within the tumor milieu,CAFs are closely associated with the aggressive biological behavior of cancer cells.Elucidating the mechanistic roles of CAFs in lung cancer and evaluating their potential as therapeutic targets hold considerable promise for advancing treatment outcomes.

  • 13.
    Thoracoscopic for lobectomy of left upper lobe anterior segment
    Wentao Li, Tianhua Zhu
    Chinese Journal of Thoracic Surgery(Electronic Edition) 2025, 12 (01): 52-52. DOI: 10.3877/cma.j.issn.2095-8773.2025.01.08
    Abstract (158) HTML (0) PDF (2230 KB) (1)
  • 14.
    Comparative analysis of different surgical approaches on chronic cough after lung surgery in patients with ≤2 cm peripheral lung adenocarcinoma
    Shijun Cui, Zhining Huang, Gaoxiang Wang, Mingsheng Wu, Xiaohui Sun, Meiqing Xu, Mingran Xie
    Chinese Journal of Thoracic Surgery(Electronic Edition) 2025, 12 (01): 24-32. DOI: 10.3877/cma.j.issn.2095-8773.2025.01.03
    Abstract (149) HTML (18) PDF (1344 KB) (31)

    Objective

    To explore the effects of different surgical methods on chronic cough after lung surgery in patients with peripheral lung adenocarcinoma with maximum tumor diameter ≤2 cm.

    Methods

    Earlystage lung adenocarcinoma patients who underwent thoracoscopic surgery at the Department of Thoracic Surgery of Provincial Hospital of Anhui Medical University from January 2021 to December 2021 were retrospectively analysed and divided into lobectomy,segmentectomy and wedge groups according to the surgical methods to analyse the effects of lobectomy,segmentectomy and wedge resection on the chronic cough of early-stage lung adenocarcinoma patients in the postoperative period.Logistic regression analysis was used to analyse the risk factors of postoperative chronic cough in patients with early-stage lung adenocarcinoma.

    Results

    The maximum diameter of tumor in the lobectomy group were larger than that in the segmentectomy and wedge resection groups,and the difference was statistically significant(P<0.001).The lung lobe group had more thoracic adhesions than the lung segment and wedge groups(P=0.015).Patients in the lung lobe group underwent more systematic lymph node dissection(P<0.001),more upper mediastinal lymph node dissection(P<0.001),and more subluxation lymph node dissection(P<0.001) than patients in the lung segment group and wedge group.Patients in the lung lobe group had longer anesthesia time and postoperative banding time than those in the lung segment and wedge groups,with significant differences(P<0.001,P<0.001).Univariate and multifactorial analyses revealed that the tumor was located in the upper lung lobe(P=0.002),lobectomy(P=0.047),systematic lymph node dissection(P<0.001),upper mediastinal lymph node dissection(P<0.001),and subglottic lymph node dissection were performed(P<0.001),and the longer the duration of anesthesia and the duration of post-operative tube banding(P<0.001,P=0.013) were independent risk influences for chronic cough after lung surgery in patients with early stage lung adenocarcinoma.

    Conclusion

    Early-stage lung adenocarcinoma patients who underwent lobectomy were more likely to develop postoperative chronic cough after lung surgery than early-stage lung adenocarcinoma patients who underwent sublobar lobectomy.In addition,when the tumor is located in the upper lobe of the lung,mediastinal lymph node dissection is performed,anesthesia time and postoperative time with tubes are long,more attention should be paid to prevent the occurrence of chronic cough after lung surgery after surgery.

  • 15.
    A case of uniport segmentectomy: RS1 combined with RS3ai+bi
    Teng Mao, Yu Yang, Xuefei Zhang, Ning Xu
    Chinese Journal of Thoracic Surgery(Electronic Edition) 2025, 12 (02): 118-118. DOI: 10.3877/cma.j.issn.2095-8773.2025.02.09
    Abstract (143) HTML (0) PDF (5894 KB) (6)
  • 16.
    Bibliometric analysis of bronchopleural fistula literature based on the Web of Science database in 1995—2024
    Haolin Guan, Jiayi Zhou, Tianning Tian, Huizhen Tang, Liang Ye
    Chinese Journal of Thoracic Surgery(Electronic Edition) 2025, 12 (02): 83-95. DOI: 10.3877/cma.j.issn.2095-8773.2025.02.03
    Abstract (114) HTML (16) PDF (11885 KB) (41)

    Objective

    To analyze the research status,hotspots,and future development trends in the field of bronchopleural fistula (BPF) by using bibliometric methods.

    Methods

    Based on the Web of Science Core Collection database,English literature related to BPF published between 1995 and 2024 was retrieved.CiteSpace and VOSviewer were employed to conduct a visual analysis of annual publication volume,countries,institutions,authors,journals,highly cited literature,and keywords.

    Results

    A total of 1 503 articles were included,showing a steady increase in publication volume over the past thirty decades. Research on BPF is primarily concentrated in the United States (403 articles),China (218 articles),Japan (167 articles),and Italy (100 articles).Mayo Clinic is the most prolific institution in this field (27 articles),while Lorenzo Spaggiari ranks first among authors(19 articles).The journal with the highest number of publications is Annals of Thoracic Surgery (184 articles).The most cited article is “Bronchopleural fistulas:an overview of the problem with special focus on endoscopic management” (290 citations). High-frequency keywords include pulmonary resection (347 occurrences),bronchopleural fistula (312 occurrences),lung cancer (194 occurrences),and empyema (170 occurrences).Keyword analysis reveals that risk factors,BPF complications,diagnostic techniques,surgical treatment,bronchoscopic intervention,and prevention are the current research hotspots.Early studies primarily focused on risk factors and treatment methods,while recent research has shifted toward prevention,long-term survival rates,and the accumulation of evidence-based medical evidence.

    Conclusion

    This study summarizes the research status and hotspots in the field of BPF through bibliometric analysis and explores potential future development trends,providing a valuable reference for scholars engaged in this field worldwide.

  • 17.
    Exploring the application of large language models in lung cancer auxiliary diagnosis and treatment
    Zhiyun Duan, Fangyi Liu, Dongxian Jiang, Qingle Wang, Wenyi Luan, Ying Wu, Tian Jiang, Han Tang, Lijie Tan
    Chinese Journal of Thoracic Surgery(Electronic Edition) 2025, 12 (03): 152-161. DOI: 10.3877/cma.j.issn.2095-8773.2025.03.05
    Abstract (112) HTML (12) PDF (4842 KB) (32)
    Objective

    To explore the current status and potential of mainstream large language models (LLMs) in lung cancer auxiliary diagnosis and treatment.

    Methods

    A multidisciplinary team from Zhongshan Hospital Affiliated to Fudan University designed 40 questions based on domestic and international guidelines and long-term clinical experience. The questions covered five modules of lung cancer diagnosis and treatment: basic concepts, lung cancer screening, diagnosis, treatment, and pathology. The questions were posed to five mainstream LLMs: DeepSeek-V3, DeepSeek-R1, Doubao, Kimi, and GPT-4o. The models’ outputs were evaluated by two experienced thoracic surgeons using a five-point Likert scale to assess accuracy and emotional support.

    Results

    GPT-4o, DeepSeek-V3, and DeepSeek-R1 performed similarly, with a median [interquartile range (IQR) ] of 5.00 (4.50–5.00), significantly outperforming Kimi [4.25 (3.50–4.50) ] and Doubao [4.50 (3.88–4.50) ]. Subgroup analysis showed that DeepSeek-R1 excelled in basic concepts, diagnosis, treatment, and pathology modules. DeepSeek-V3 performed excellently overall, particularly in the diagnosis module. GPT-4o was best suited for the screening module. The emotional support assessment revealed that all LLMs scored notably lower in this dimension, around 3.00, compared to their accuracy scores. Among the models, DeepSeek-R1 provided the highest level of emotional support, with a median (IQR) of 3.50 (3.00–4.50). GPT-4o [2.50 (2.50–3.12) ], DeepSeek-V3 [3.25 (2.50–3.50) ], and Doubao [3.00 (2.50–3.50) ] demonstrated comparable performance, while Kimi showed the lowest scores [2.50 (2.50–3.00) ]. Subgroup analysis further indicated that emotional support ratings were consistently lower across all modules, highlighting a critical limitation of current LLMs in patient-centered communication.

    Conclusions

    LLMs show initial application potential in lung cancer diagnosis and treatment, but shortcomings remain in handling complex clinical scenarios and patient communication. With ongoing development and improvement, LLMs are expected to have broad application prospects in the field of lung cancer diagnosis and treatment. To the best of our knowledge, our study is the first systematic evaluation of domestic LLMs in the context of lung cancer care in China.

  • 18.
    A case of early postoperative bronchopleural fistula after lung cancer surgery treated with emergency sleeve resection
    Yu Zhu, Zepeng Zhao, Tao Zhang, Jianfeng Wang, Ming Ma, Xia Li, yanhong Liu
    Chinese Journal of Thoracic Surgery(Electronic Edition) 2025, 12 (02): 112-115. DOI: 10.3877/cma.j.issn.2095-8773.2025.02.06
  • 19.
    Expert guidance on radical esophagectomy (McKeown procedure) under non-intubation anesthesia (2025)
    Chinese Society of Esophageal Diseases, Guangdong Thoracic Diseases Society
    Chinese Journal of Thoracic Surgery(Electronic Edition) 2025, 12 (03): 119-129. DOI: 10.3877/cma.j.issn.2095-8773.2025.03.01
    Abstract (108) HTML (21) PDF (5103 KB) (88)

    This guideline is jointly developed by the Chinese Society of Esophageal Diseases and the Guangdong Thoracic Diseases Society. Based on existing literature and the clinical experience of the participating experts, the guideline summarizes the application of non-intubation anesthesia technique in thoracoabdominal laparoscopic esophagectomy (the McKeown procedure), aiming to provide practical references for medical centers that intend to implement the McKeown. The guideline systematically outlines the indications and contraindications of non-intubated anesthesia, emphasizing patient selection criteria such as American Society of Anesthesiologists (ASA) class ≤2 and good cardiopulmonary function, while excluding severe comorbidities or airway abnormalities. Preoperative preparation includes comprehensive evaluation, nutritional support, cardiopulmonary exercise, and dietary adjustments. Anesthetic techniques involve epidural anesthesia, thoracic paravertebral nerve block, and laryngeal mask airway placement, with two recommended anesthesia protocols for optimized intraoperative management. The surgical workflow details patient positioning, incision design, and key steps in thoracic, abdominal, and cervical operations, highlighting the advantages of minimally invasive techniques and spontaneous ventilation management. Anesthesia management focuses on preventing and addressing complications such as hypercapnia, hypoxemia, and laryngeal mask displacement, with clear criteria for conversion to tracheal intubation. Postoperative analgesia adopts a multimodal strategy to enhance recovery. The guideline concludes that non-intubated anesthesia offers advantages of reduced trauma and faster recovery but requires individualized management to ensure safety. With technological advancements, this approach is expected to further promote minimally invasive esophageal cancer surgery.

京ICP 备07035254号-28
Copyright © Chinese Journal of Thoracic Surgery(Electronic Edition), All Rights Reserved.
Tel: 021-22200819 Fax: (010)85158381 E-mail: editor@thecjts.cn
Powered by Beijing Magtech Co. Ltd